SDS-PAGE of recombinant and endogenous erythropoietins: benefits and limitations of the method for application in doping control.
about
Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.The uefa euro 2012 anti-doping programme - scientific reviewEvaluation of AMGEN clone 9G8A anti-Epo antibody for application in doping control.Detection of EPO injections using a rapid lateral flow isoform test.Site-specific qualitative and quantitative analysis of the N- and O-glycoforms in recombinant human erythropoietin.Surface plasmon resonance in doping analysis.Recent developments in doping testing for erythropoietin.Detection of erythropoiesis-stimulating agents in human anti-doping control: past, present and future.Gel electrophoretic methods for the analysis of biosimilar pharmaceuticals using the example of recombinant erythropoietin.Current strategies of blood doping detection.Detection of peptidic erythropoiesis-stimulating agents in sport.A modified procedure based on a vacuum-driven blotting system for the detection of erythropoietin and its analogs.Detecting peptidic drugs, drug candidates and analogs in sports doping: current status and future directions.The overlooked difference between human endogenous and recombinant erythropoietins and its implication for sports drug testing and pharmaceutical drug design.Identification of recombinant human EPO variants in greyhound plasma and urine by ELISA, LC-MS/MS and western blotting: a comparative study.Emerging drugs: mechanism of action, mass spectrometry and doping control analysis.A rapid and simple assay to determine pegylated erythropoietin in human serum.New insights for identification of doping with recombinant human erythropoietin micro-doses after high hydration.Desialylation improves the detection of recombinant erythropoietins in urine samples analyzed by SDS-PAGE.Surface-enhanced Raman probe for rapid nanoextraction and detection of erythropoietin in urine.Transposon-modified antigen-specific T lymphocytes for sustained therapeutic protein delivery in vivo.Detection of recombinant EPO in blood and urine samples with EPO WGA MAIIA, IEF and SAR-PAGE after microdose injections.
P2860
Q30409171-0314862A-255C-401E-BC15-03281DA65E2DQ33703035-762BBAFF-5E2D-4F7D-B262-E866F7DC441CQ34538186-AE42E03E-F546-4649-8585-B34C57596C5EQ34711535-9B2F5892-835B-4F8A-BDAF-E66B2BEA8C0EQ35577821-8218E653-C0A5-4020-A1D4-4D441BD6B311Q37859306-09E88F9D-F239-419E-983D-EC517DDE6099Q37884431-A3BDE850-85FA-45D0-9D7C-19B023187B89Q38029405-56C42DA7-2598-48CC-8AE8-34FFCE328488Q38083095-D4357433-2302-418C-B232-CD79680FF217Q38128215-18091087-0412-49EE-B07B-95B2AA51FCBCQ38200014-690EC3E6-1A94-42B9-A2A0-B649B977254AQ38970172-9F19E6F9-CDB1-4A90-AF02-3411D8F0E560Q39100829-55C5971A-DB90-4C7C-B9B0-6BE4BF78C566Q39433211-41914867-AD64-4C04-BCCE-DDEEADE9D04BQ40625431-8CA8A498-BC09-47A0-9067-2403F216633DQ47992683-47327150-3DC3-4A55-94F9-37B3E754BE9DQ49114390-5424B4DE-3194-46EE-B79B-BE9352F7C4CBQ50615051-C3FBD7EF-21E6-4DAD-AD4A-D88237A68CE6Q50951247-E5019455-49B6-4761-89F0-25DFC7C728FFQ51141263-3C1CA7DD-692B-4CAC-86F9-172C52F024EAQ52720213-BA96F709-15EB-466A-B291-2118EB8247AEQ54662600-9E582087-5CD9-4F08-952E-831AA7E0B483
P2860
SDS-PAGE of recombinant and endogenous erythropoietins: benefits and limitations of the method for application in doping control.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
SDS-PAGE of recombinant and en ...... application in doping control.
@en
type
label
SDS-PAGE of recombinant and en ...... application in doping control.
@en
prefLabel
SDS-PAGE of recombinant and en ...... application in doping control.
@en
P2093
P356
P1476
SDS-PAGE of recombinant and en ...... application in doping control.
@en
P2093
Christian Reichel
Martina Watzinger
Ronald Kulovics
Thomas Geisendorfer
Veronika Jordan
P356
10.1002/DTA.10
P577
2009-01-01T00:00:00Z